Joseph P. Hagan
2009 - Orexigen Therapeutics
In 2009, Joseph P. Hagan earned a total compensation of $566.9K as Chief Business Officer at Orexigen Therapeutics.
Compensation breakdown
| Bonus | $87,000 |
|---|---|
| Option Awards | $286,580 |
| Salary | $193,269 |
| Other | $80 |
| Total | $566,929 |
Hagan received $286.6K in option awards, accounting for 51% of the total pay in 2009.
Hagan also received $87K in bonus, $193.3K in salary and $80 in other compensation.
Rankings
In 2009, Joseph P. Hagan's compensation ranked 6,407th out of 9,885 executives tracked by ExecPay. In other words, Hagan earned more than 35.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,407 out of 9,885 | 35th |
Division Manufacturing | 2,336 out of 3,690 | 37th |
Major group Chemicals And Allied Products | 508 out of 866 | 41st |
Industry group Drugs | 343 out of 638 | 46th |
Industry Pharmaceutical Preparations | 244 out of 446 | 45th |
Source: SEC filing on April 27, 2012.
Hagan's colleagues
We found seven more compensation records of executives who worked with Joseph P. Hagan at Orexigen Therapeutics in 2009.
2009
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2009
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer
2009
Preston Klassen
Orexigen Therapeutics
Head of Global Contrave Program and Senior Vice President, Product Development
2009
Dawn Viveash
Orexigen Therapeutics
Senior Vice President, Regulatory Affairs
2009
Graham Cooper
Orexigen Therapeutics
Chief Financial Officer
2009
Heather Turner
Orexigen Therapeutics
General Counsel
2009
Eckard Weber
Orexigen Therapeutics
Chief Executive Officer
News
Regulus Therapeutics CEO Joseph Hagan's 2021 pay falls 22% to $1.8M
April 27, 2022
Regulus Therapeutics CEO Joseph Hagan's 2020 pay rises 16% to $2.3M
April 30, 2021
Regulus Therapeutics CEO Joseph Hagan's 2019 pay slips 14% to $2M
April 29, 2020
Regulus Therapeutics CEO Joseph Hagan's 2018 pay jumps 22% to $2.3M
July 1, 2019